Industry: Pharma & Healthcare
Published Date: 2024-04-17
Pages: 160 Pages
Report ld: 2695637
Request Sample
Customized Report
Paracetamol Market Size(US$)

CAGR 2024-2030
2.5%
Market Size,2030
USD 1,371.7
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Paracetamol also known as acetaminophen or APAP is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness. In prescription medicines, acetaminophen is found with other active ingredients to treat moderate to severe pain. Acetaminophen can cause serious liver damage if more than directed is used.
The global Paracetamol market size was US$ 1325.8 million in 2023 and is forecast to a readjusted size of US$ 1371.7 million by 2030 with a CAGR of 2.5% during the forecast period 2024-2030.
Global key players of paracetamol include Mallinckrodt, Anqiu Lu'an, Granules India, Farmson, Hebei Jiheng, etc. The top five players hold a share about 66%. Asia Pacific is the largest market, with a share over 55%, followed by Europe and North America, both have a share over 15 percent. Based on the product type, the Paracetamol is primarily split into Powder Type and Granule Type. The leading type is Powder Type, with a market share about 85%.
Based on the Application, the Paracetamol is primarily split into Tablet Drug, Granule Drug and Suspension Drug. The largest segment is Tablet Drug.
In terms of sales (consumption) side, this report focuses on the sales of Paracetamol by regions (Countries), company, by type and by type. from 2019 to 2024 and forecast to 2030.
The global Paracetamol market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Paracetamol market. These figures have been provided in terms of both revenue and sales for the period 2019-2030. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Paracetamol in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Paracetamol manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7: Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8: China by company, by type and by application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Paracetamol sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Paracetamol Definition
1.2 Market by Type
1.2.1 Global Paracetamol Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Paracetamol Powder
1.2.3 Paracetamol Granule
1.3 Market Segment by Application
1.3.1 Global Paracetamol Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Tablet Drug
1.3.3 Granule Drug
1.3.4 Suspension Drug
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Paracetamol Sales
2.1 Global Paracetamol Revenue Estimates and Forecasts 2019-2030
2.2 Global Paracetamol Revenue by Region: 2019 VS 2023 VS 2030
2.3 Global Paracetamol Revenue by Region
2.3.1 Global Paracetamol Revenue by Region (2019-2024)
2.3.2 Global Paracetamol Revenue by Region (2025-2030)
2.4 Global Paracetamol Sales Quantity Estimates and Forecasts 2019-2030
2.5 Global Paracetamol Sales Quantity by Region: 2019 VS 2023 VS 2030
2.6 Global Paracetamol Sales Quantity by Region
2.6.1 Global Paracetamol Sales Quantity by Region (2019-2024)
2.6.2 Global Paracetamol Sales Quantity by Region (2025-2030)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Paracetamol Sales Quantity by Manufacturers
3.1.1 Global Paracetamol Sales Quantity by Manufacturers (2019-2024)
3.1.2 Global Paracetamol Sales Quantity Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Companies by Paracetamol Sales in 2023
3.2 Global Paracetamol Revenue by Manufacturers
3.2.1 Global Paracetamol Revenue by Manufacturers (2019-2024)
3.2.2 Global Paracetamol Revenue Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Paracetamol Revenue in 2023
3.3 Global Paracetamol Sales Price by Manufacturers
3.4 Global Key Players of Paracetamol, Industry Ranking, 2022 VS 2023
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Paracetamol Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Paracetamol, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Paracetamol, Product Offered and Application
3.8 Global Key Manufacturers of Paracetamol, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Paracetamol Sales Quantity by Type
4.1.1 Global Paracetamol Historical Sales Quantity by Type (2019-2024)
4.1.2 Global Paracetamol Forecasted Sales Quantity by Type (2025-2030)
4.1.3 Global Paracetamol Sales Quantity Market Share by Type (2019-2030)
4.2 Global Paracetamol Revenue by Type
4.2.1 Global Paracetamol Historical Revenue by Type (2019-2024)
4.2.2 Global Paracetamol Forecasted Revenue by Type (2025-2030)
4.2.3 Global Paracetamol Revenue Market Share by Type (2019-2030)
4.3 Global Paracetamol Price by Type
4.3.1 Global Paracetamol Price by Type (2019-2024)
4.3.2 Global Paracetamol Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Paracetamol Sales Quantity by Application
5.1.1 Global Paracetamol Historical Sales Quantity by Application (2019-2024)
5.1.2 Global Paracetamol Forecasted Sales Quantity by Application (2025-2030)
5.1.3 Global Paracetamol Sales Quantity Market Share by Application (2019-2030)
5.2 Global Paracetamol Revenue by Application
5.2.1 Global Paracetamol Historical Revenue by Application (2019-2024)
5.2.2 Global Paracetamol Forecasted Revenue by Application (2025-2030)
5.2.3 Global Paracetamol Revenue Market Share by Application (2019-2030)
5.3 Global Paracetamol Price by Application
5.3.1 Global Paracetamol Price by Application (2019-2024)
5.3.2 Global Paracetamol Price Forecast by Application (2025-2030)
6 North America
6.1 North America Paracetamol Sales by Company
6.1.1 North America Paracetamol Revenue by Company (2019-2024)
6.1.2 North America Paracetamol Sales Quantity by Company (2019-2024)
6.2 North America Paracetamol Market Size by Type
6.2.1 North America Paracetamol Sales Quantity by Type (2019-2030)
6.2.2 North America Paracetamol Revenue by Type (2019-2030)
6.3 North America Paracetamol Market Size by Application
6.3.1 North America Paracetamol Sales Quantity by Application (2019-2030)
6.3.2 North America Paracetamol Revenue by Application (2019-2030)
6.4 North America Paracetamol Market Size by Country
6.4.1 North America Paracetamol Revenue by Country: 2019 VS 2023 VS 2030
6.4.2 North America Paracetamol Revenue by Country (2019-2030)
6.4.3 North America Paracetamol Sales Quantity by Country (2019-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Paracetamol Sales by Company
7.1.1 Europe Paracetamol Sales Quantity by Company (2019-2024)
7.1.2 Europe Paracetamol Revenue by Company (2019-2024)
7.2 Europe Paracetamol Market Size by Type
7.2.1 Europe Paracetamol Sales Quantity by Type (2019-2030)
7.2.2 Europe Paracetamol Revenue by Type (2019-2030)
7.3 Europe Paracetamol Market Size by Application
7.3.1 Europe Paracetamol Sales Quantity by Application (2019-2030)
7.3.2 Europe Paracetamol Revenue by Application (2019-2030)
7.4 Europe Paracetamol Market Size by Country
7.4.1 Europe Paracetamol Revenue by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Paracetamol Revenue by Country (2019-2030)
7.4.3 Europe Paracetamol Sales Quantity by Country (2019-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Paracetamol Sales by Company
8.1.1 China Paracetamol Sales Quantity by Company (2019-2024)
8.1.2 China Paracetamol Revenue by Company (2019-2024)
8.2 China Paracetamol Market Size by Type
8.2.1 China Paracetamol Sales Quantity by Type (2019-2030)
8.2.2 China Paracetamol Revenue by Type (2019-2030)
8.3 China Paracetamol Market Size by Application
8.3.1 China Paracetamol Sales Quantity by Application (2019-2030)
8.3.2 China Paracetamol Revenue by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Paracetamol Sales by Company
9.1.1 APAC Paracetamol Sales Quantity by Company (2019-2024)
9.1.2 APAC Paracetamol Revenue by Company (2019-2024)
9.2 APAC Paracetamol Market Size by Type
9.2.1 APAC Paracetamol Sales Quantity by Type (2019-2030)
9.2.2 APAC Paracetamol Revenue by Type (2019-2030)
9.3 APAC Paracetamol Market Size by Application
9.3.1 APAC Paracetamol Sales Quantity by Application (2019-2030)
9.3.2 APAC Paracetamol Revenue by Application (2019-2030)
9.4 APAC Paracetamol Market Size by Region
9.4.1 APAC Paracetamol Revenue by Region: 2019 VS 2023 VS 2030
9.4.2 APAC Paracetamol Revenue by Region (2019-2030)
9.4.3 APAC Paracetamol Sales Quantity by Region (2019-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Paracetamol Sales by Company
10.1.1 Middle East, Africa and Latin America Paracetamol Sales Quantity by Company (2019-2024)
10.1.2 Middle East, Africa and Latin America Paracetamol Revenue by Company (2019-2024)
10.2 Middle East, Africa and Latin America Paracetamol Market Size by Type
10.2.1 Middle East, Africa and Latin America Paracetamol Sales Quantity by Type (2019-2030)
10.2.2 Middle East, Africa and Latin America Paracetamol Revenue by Type (2019-2030)
10.3 Middle East, Africa and Latin America Paracetamol Market Size by Application
10.3.1 Middle East, Africa and Latin America Paracetamol Sales Quantity by Application (2019-2030)
10.3.2 Middle East, Africa and Latin America Paracetamol Revenue by Application (2019-2030)
10.4 Middle East, Africa and Latin America Paracetamol Market Size by Country
10.4.1 Middle East, Africa and Latin America Paracetamol Revenue by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa and Latin America Paracetamol Revenue by Country (2019-2030)
10.4.3 Middle East, Africa and Latin America Paracetamol Sales Quantity by Country (2019-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Mallinckrodt
11.1.1 Mallinckrodt Company Information
11.1.2 Mallinckrodt Overview
11.1.3 Mallinckrodt Paracetamol Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.1.4 Mallinckrodt Paracetamol Products and Services
11.1.5 Mallinckrodt Paracetamol SWOT Analysis
11.1.6 Mallinckrodt Recent Developments
11.2 Anqiu Lu'an
11.2.1 Anqiu Lu'an Company Information
11.2.2 Anqiu Lu'an Overview
11.2.3 Anqiu Lu'an Paracetamol Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.2.4 Anqiu Lu'an Paracetamol Products and Services
11.2.5 Anqiu Lu'an Paracetamol SWOT Analysis
11.2.6 Anqiu Lu'an Recent Developments
11.3 Granules India
11.3.1 Granules India Company Information
11.3.2 Granules India Overview
11.3.3 Granules India Paracetamol Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.3.4 Granules India Paracetamol Products and Services
11.3.5 Granules India Paracetamol SWOT Analysis
11.3.6 Granules India Recent Developments
11.4 Farmson
11.4.1 Farmson Company Information
11.4.2 Farmson Overview
11.4.3 Farmson Paracetamol Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.4.4 Farmson Paracetamol Products and Services
11.4.5 Farmson Paracetamol SWOT Analysis
11.4.6 Farmson Recent Developments
11.5 Hebei Jiheng Pharmaceutical
11.5.1 Hebei Jiheng Pharmaceutical Company Information
11.5.2 Hebei Jiheng Pharmaceutical Overview
11.5.3 Hebei Jiheng Pharmaceutical Paracetamol Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.5.4 Hebei Jiheng Pharmaceutical Paracetamol Products and Services
11.5.5 Hebei Jiheng Pharmaceutical Paracetamol SWOT Analysis
11.5.6 Hebei Jiheng Pharmaceutical Recent Developments
11.6 Zhejiang Kangle
11.6.1 Zhejiang Kangle Company Information
11.6.2 Zhejiang Kangle Overview
11.6.3 Zhejiang Kangle Paracetamol Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.6.4 Zhejiang Kangle Paracetamol Products and Services
11.6.5 Zhejiang Kangle Paracetamol SWOT Analysis
11.6.6 Zhejiang Kangle Recent Developments
11.7 Sri Krishna Pharma
11.7.1 Sri Krishna Pharma Company Information
11.7.2 Sri Krishna Pharma Overview
11.7.3 Sri Krishna Pharma Paracetamol Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.7.4 Sri Krishna Pharma Paracetamol Products and Services
11.7.5 Sri Krishna Pharma Paracetamol SWOT Analysis
11.7.6 Sri Krishna Pharma Recent Developments
11.8 Anhui BBCA Likang
11.8.1 Anhui BBCA Likang Company Information
11.8.2 Anhui BBCA Likang Overview
11.8.3 Anhui BBCA Likang Paracetamol Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.8.4 Anhui BBCA Likang Paracetamol Products and Services
11.8.5 Anhui BBCA Likang Paracetamol SWOT Analysis
11.8.6 Anhui BBCA Likang Recent Developments
11.9 Seqens
11.9.1 Seqens Company Information
11.9.2 Seqens Overview
11.9.3 Seqens Paracetamol Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.9.4 Seqens Paracetamol Products and Services
11.9.5 Seqens Paracetamol SWOT Analysis
11.9.6 Seqens Recent Developments
11.10 Atabay
11.10.1 Atabay Company Information
11.10.2 Atabay Overview
11.10.3 Atabay Paracetamol Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.10.4 Atabay Paracetamol Products and Services
11.10.5 Atabay Paracetamol SWOT Analysis
11.10.6 Atabay Recent Developments
11.11 Anhui Fubore
11.11.1 Anhui Fubore Company Information
11.11.2 Anhui Fubore Overview
11.11.3 Anhui Fubore Paracetamol Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.11.4 Anhui Fubore Paracetamol Products and Services
11.11.5 Anhui Fubore Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Paracetamol Value Chain Analysis
12.2 Paracetamol Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Paracetamol Production Mode & Process
12.4 Paracetamol Sales and Marketing
12.4.1 Paracetamol Sales Channels
12.4.2 Paracetamol Distributors
12.5 Paracetamol Customers
13 Market Dynamics
13.1 Paracetamol Industry Trends
13.2 Paracetamol Market Drivers
13.3 Paracetamol Market Challenges
13.4 Paracetamol Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Paracetamol market is projected to grow from US$ 962 million in 2025 to US$ 1065 million by 2032, at a CAGR of 1.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-04-16
Pages: 151
USD 4900.00
(Single User License)
The global Paracetamol market size was US$ 962 million in 2025 and is forecast to reach a readjusted size of US$ 1065 million by 2032 with a CAGR of 1.5% during the forecast period 2026-2032.
Published Date: 2026-04-16
Pages: 144
USD 4250.00
(Single User License)
The global Paracetamol market was valued at US$ 962 million in 2025 and is anticipated to reach US$ 1065 million by 2032, at a CAGR of 1.5% from 2026 to 2032.
Published Date: 2026-04-16
Pages: 118
USD 2900.00
(Single User License)
The global market for Paracetamol was estimated to be worth US$ 962 million in 2025 and is projected to reach US$ 1065 million, growing at a CAGR of 1.5% from 2026 to 2032.
Published Date: 2026-04-16
Pages: 139
USD 3950.00
(Single User License)
The global Paracetamol market is projected to grow from US$ 1208 million in 2024 to US$ 1435 million by 2031, at a CAGR of 2.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 154
USD 4900.00
(Single User License)
In 2024, the global market size of Paracetamol was estimated to be worth US$ 1208 million and is forecast to reach approximately US$ 1435 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 158
USD 5900.00
(Single User License)
The global Paracetamol market size was US$ 1208 million in 2024 and is forecast to a readjusted size of US$ 1435 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 97
USD 4250.00
(Single User License)
The global market for Paracetamol was estimated to be worth US$ 1208 million in 2024 and is forecast to a readjusted size of US$ 1435 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 128
USD 3950.00
(Single User License)
The global market for Paracetamol was valued at US$ 1208 million in the year 2024 and is projected to reach a revised size of US$ 1435 million by 2031, growing at a CAGR of 2.5% during the forecast period.
Published Date: 2025-01-16
Pages: 96
USD 2900.00
(Single User License)
Paracetamol also known as acetaminophen or APAP is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness. In prescription medicines, acetaminophen is found with other active ingredients to treat moderate to severe pain. Acetaminophen can cause serious liver damage if more than directed is used.
Published Date: 2024-04-16
Pages: 149
USD 5900.00
(Single User License)
The global Paracetamol market is projected to grow from US$ 962 million in 2025 to US$ 1065 million by 2032, at a CAGR of 1.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-04-16
Pages: 151
The global Paracetamol market size was US$ 962 million in 2025 and is forecast to reach a readjusted size of US$ 1065 million by 2032 with a CAGR of 1.5% during the forecast period 2026-2032.
Published: 2026-04-16
Pages: 144
The global Paracetamol market was valued at US$ 962 million in 2025 and is anticipated to reach US$ 1065 million by 2032, at a CAGR of 1.5% from 2026 to 2032.
Published: 2026-04-16
Pages: 118
The global market for Paracetamol was estimated to be worth US$ 962 million in 2025 and is projected to reach US$ 1065 million, growing at a CAGR of 1.5% from 2026 to 2032.
Published: 2026-04-16
Pages: 139
The global Paracetamol market is projected to grow from US$ 1208 million in 2024 to US$ 1435 million by 2031, at a CAGR of 2.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 154
In 2024, the global market size of Paracetamol was estimated to be worth US$ 1208 million and is forecast to reach approximately US$ 1435 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 158
The global Paracetamol market size was US$ 1208 million in 2024 and is forecast to a readjusted size of US$ 1435 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 97
The global market for Paracetamol was estimated to be worth US$ 1208 million in 2024 and is forecast to a readjusted size of US$ 1435 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 128
The global market for Paracetamol was valued at US$ 1208 million in the year 2024 and is projected to reach a revised size of US$ 1435 million by 2031, growing at a CAGR of 2.5% during the forecast period.
Published: 2025-01-16
Pages: 96
Paracetamol also known as acetaminophen or APAP is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness. In prescription medicines, acetaminophen is found with other active ingredients to treat moderate to severe pain. Acetaminophen can cause serious liver damage if more than directed is used.
Published: 2024-04-16
Pages: 149
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now